Media Lab SpAXPAR:MLLAB -12.50%76 PS Ratio is 4.74 as of Jul. 07, 2026, which is 26% above its 10-year median of 3.75. GuruFocus rates XPAR:MLLAB with a GF Score™ of 76/100 and a GF Value™ of €1.74 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Media Lab SpA ranks worse than 82.34% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Media Lab SpA's share price is €2.80.
Media Lab SpA's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.59. Hence, Media Lab SpA's PS Ratio for today is 4.74.
The historical rank and industry rank for Media Lab SpA's PS Ratio or its related term are showing as below:
XPAR:MLLAB'
s PS Ratio Range Over the Past 10 Years
Min: 1.54 Med: 3.75 Max: 19.54
Current: 5.41
During the past 11 years, Media Lab SpA's highest PS Ratio was 19.54. The lowest was 1.54. And the median was 3.75.
XPAR:MLLAB's PS Ratio is ranked worse than 82.34% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 1.5
vs XPAR:MLLAB: 5.41
Media Lab SpA revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Media Lab SpA was -23.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 6.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 10.80% per year.
During the past 11 years, Media Lab SpA's highest 3-Year average Revenue per Share Growth Rate was 24.50% per year. The lowest was -1.50% per year. And the median was 12.05% per year.
Back to Basics: PS Ratio
Media Lab SpA (XPAR:MLLAB) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Media Lab SpA PS Ratio Related Terms
Media Lab SpA PS Ratio Historical Data
* Premium members only.
The historical data trend for Media Lab SpA's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLLAB vs VEEV, BTSG, TEM: PS Ratio Comparison
For the Health Information Services subindustry, Media Lab SpA's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Media Lab SpA PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Media Lab SpA's PS Ratio distribution charts can be found below:
* The bar in red indicates where Media Lab SpA's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Media Lab SpA's Share Price of today is €2.80.
For company reported annually, GuruFocus uses latest annual data as the TTM data. Media Lab SpA's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.59.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Media Lab SpA (XPAR:MLLAB) has a PS Ratio of 4.74 as of Jul. 07, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Media Lab SpA and its competitors. This is 26% above median its historical median of 3.75. Over the past decade, Media Lab SpA's PS Ratio has ranged from 1.54 to 19.54. According to the industry distribution chart, Media Lab SpA ranks #541 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 82.3%.
Is Media Lab SpA's PS Ratio too high?
Media Lab SpA's current PS Ratio of 4.74 is 26% above median its 10-year median of 3.75. Over the past 10 years, this metric has ranged from a low of 1.54 to a high of 19.54. The Healthcare Providers & Services industry median PS Ratio is 1.50. Media Lab SpA's value of 4.74 is 216% above this industry median. Based on the distribution chart, Media Lab SpA ranks #541 out of 657 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Media Lab SpA has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Media Lab SpA's PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Media Lab SpA ranks #541 out of 657 companies for PS Ratio. This places Media Lab SpA in the lower half of its industry. The industry median PS Ratio is 1.50. Media Lab SpA's value of 4.74 is 216% above this benchmark. Historically, Media Lab SpA's own PS Ratio has ranged from 1.54 to 19.54 over the past decade. While the company's 10-year median is 3.75 vs. the industry median of 1.50, Media Lab SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.50, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Media Lab SpA's current PS Ratio of 4.74 is 216% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Media Lab SpA and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Media Lab SpA's current PS Ratio is 4.74, which is 26% above median its own 10-year median of 3.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Media Lab SpA stock overvalued right now?
Based on GuruFocus' analysis, Media Lab SpA (XPAR:MLLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.74, compared to a current price of €2.80 — trading 60.9% above its estimated fair value. The current PS Ratio is 4.74, which is 26% above median its 10-year median of 3.75 and 216% above the Healthcare Providers & Services industry median of 1.50. Media Lab SpA's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Media Lab SpA (XPAR:MLLAB), the current PS Ratio is 4.74 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Media Lab SpA (XPAR:MLLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Media Lab SpA stock appears to be overvalued.
The current stock price of €2.80 is trading 60.9% above its estimated GF Value™ of €1.74.
GuruFocus considers Media Lab SpA to be Significantly Overvalued.
Key valuation signals for XPAR:MLLAB:
PS Ratio: 4.74 (26% above median its 10-year median of 3.75)
GF Value™: €1.74 vs. price of €2.80 (60.9% above fair value)
Industry Position: 216% above the Healthcare Providers & Services median (#541 of 657)
No single metric tells the full story. See the XPAR:MLLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Media Lab SpA provides IT services for the dental sector. It is engaged in the development of software dedicated to the dental market. The company's products include Implant 3D, Guidedesign, Confident among others.
76GF Score
Get the complete analysis for XPAR:MLLAB
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLLAB has been successfully added to your 
